Cargando…

Suboptimal Dosing of β-Blockers in Chronic Heart Failure: A Missed Opportunity?

The evidence base for the benefits of β-blockers in heart failure with reduced ejection fraction (HFrEF) suggests that higher doses are associated with better outcomes. OBJECTIVES: The aim of this study was to report the proportion of patients receiving optimized doses of β-blockers, outcomes, and f...

Descripción completa

Detalles Bibliográficos
Autores principales:	McGinlay, Melanie, Straw, Sam, Byrom-Goulthorp, Rowenna, Relton, Samuel D., Gierula, John, Cubbon, Richard M., Kearney, Mark T., Witte, Klaus K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	ARTICLES: Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613698/ https://www.ncbi.nlm.nih.gov/pubmed/34321430 http://dx.doi.org/10.1097/JCN.0000000000000847

Ejemplares similares

Four pillars of heart failure: contemporary pharmacological therapy for heart failure with reduced ejection fraction
por: Straw, Sam, et al.
Publicado: (2021)

Prioritizing symptom management in the treatment of chronic heart failure
por: Koshy, Aaron O., et al.
Publicado: (2020)

Effect of disease‐modifying agents and their association with mortality in multi‐morbid patients with heart failure with reduced ejection fraction
por: Straw, Sam, et al.
Publicado: (2020)

Personalised reprogramming to prevent progressive pacemaker-related left ventricular dysfunction: A phase II randomised, controlled clinical trial
por: Paton, Maria F., et al.
Publicado: (2021)

Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
por: Straw, Sam, et al.
Publicado: (2022)

Atrial fibrillation and risk of progressive heart failure in patients with preserved ejection fraction heart failure
por: Gierula, John, et al.
Publicado: (2022)

Association of heart failure and its comorbidities with loss of life expectancy
por: Drozd, Michael, et al.
Publicado: (2021)

Reduction of heart failure guideline‐directed medication during hospitalization: prevalence, risk factors, and outcomes
por: Palin, Victoria, et al.
Publicado: (2022)

Advanced care planning during the COVID-19 pandemic: ceiling of care decisions and their implications for observational data
por: Straw, Sam, et al.
Publicado: (2021)

Correction: Advanced care planning during the COVID-19 pandemic: ceiling of care decisions and their implications for observational data
por: Straw, Sam, et al.
Publicado: (2022)

Prevalence and Predictors of Sepsis Death in Patients With Chronic Heart Failure and Reduced Left Ventricular Ejection Fraction
por: Walker, Andrew M. N., et al.
Publicado: (2018)

Performance of 2014 NICE defibrillator implantation guidelines in heart failure risk stratification
por: Cubbon, Richard M, et al.
Publicado: (2016)

Unique Transcriptome Signature Distinguishes Patients With Heart Failure With Myopathy
por: Caspi, Talia, et al.
Publicado: (2020)

Diabetes, gender and deterioration in estimated glomerular filtration rate in patients with chronic heart failure: Ten-year prospective cohort study
por: Kearney, Jessica, et al.
Publicado: (2021)

Socioeconomic deprivation and mode-specific outcomes in patients with chronic heart failure
por: Witte, Klaus K, et al.
Publicado: (2018)

Vitamin D deficiency is an independent predictor of mortality in patients with chronic heart failure
por: Cubbon, Richard M., et al.
Publicado: (2018)

Diabetes mellitus and the causes of hospitalisation in people with heart failure
por: Malik, Anam, et al.
Publicado: (2022)

Optimising pacemaker therapy and medical therapy in pacemaker patients for heart failure: protocol for the OPT-PACE randomised controlled trial
por: Paton, Maria F, et al.
Publicado: (2019)

Quantifying the relationship and contribution of mitochondrial respiration to systemic exercise limitation in heart failure
por: Knuiman, Pim, et al.
Publicado: (2021)

Non-communicable disease, sociodemographic factors, and risk of death from infection: a UK Biobank observational cohort study
por: Drozd, Michael, et al.
Publicado: (2021)

‘Acute Heart Failure’: Should We Abandon the Term Altogether?
por: Straw, Sam, et al.
Publicado: (2022)

Ischemic Heart Disease Modifies the Association of Atrial Fibrillation With Mortality in Heart Failure With Reduced Ejection Fraction
por: Mercer, Ben N., et al.
Publicado: (2018)

Causes of Death in People With Cardiovascular Disease: A UK Biobank Cohort Study
por: Drozd, Michael, et al.
Publicado: (2021)

Chronic heart failure with diabetes mellitus is characterized by a severe skeletal muscle pathology
por: Garnham, Jack O., et al.
Publicado: (2019)

Atrial secondary mitral regurgitation: prevalence, characteristics, management, and long-term outcomes
por: Straw, Sam, et al.
Publicado: (2023)

Divergent skeletal muscle mitochondrial phenotype between male and female patients with chronic heart failure
por: Garnham, Jack O., et al.
Publicado: (2019)

Rhizomelic chondrodysplasia punctata: A missed opportunity for early diagnosis
por: Chhavi, Nanda, et al.
Publicado: (2012)

Effects of Vitamin D on Cardiac Function in Patients With Chronic HF: The VINDICATE Study
por: Witte, Klaus K., et al.
Publicado: (2016)

Ambulatory heart rate range predicts mode-specific mortality and hospitalisation in chronic heart failure
por: Cubbon, Richard M, et al.
Publicado: (2016)

Fortune or failure: missed opportunities and chance discoveries
por: Kohn, Alexander
Publicado: (1989)

An enormous right atrial myxoma highlights the role of echocardiography in heart failure pathways: a case report
por: Straw, Sam, et al.
Publicado: (2022)

Skeletal muscle atrophy in heart failure with diabetes: from molecular mechanisms to clinical evidence
por: Wood, Nathanael, et al.
Publicado: (2020)

Clinical implications and risk factors for QRS prolongation over time in heart failure patients
por: Berger, Martin, et al.
Publicado: (2022)

Vaccine Coverage for United States Infants at Milestone Ages: Missed Opportunities for Vaccination
por: Gebremeskel, Berhanu G., et al.
Publicado: (2016)

Colorectal cancer in an Eastern Caribbean nation: are we missing an opportunity for secondary prevention?
por: Cawich, Shamir O., et al.
Publicado: (2022)

Secondary mitral regurgitation: reducing the leak, expanding the science
por: Straw, Sam, et al.
Publicado: (2020)

A Case of Congenital Infection: Missed Opportunities for Prevention and the Importance of Maternal Testing and Screening
por: Heisler, Shira, et al.
Publicado: (2017)

Fortune or failure: missed opportunities and chance discoveries in science
por: Wolpert, Lewis
Publicado: (1991)

COVID-19 and the Gaping Wounds of South Africa’s Suboptimal Immunisation Coverage: An Implementation Research Imperative for Assessing and Addressing Missed Opportunities for Vaccination
por: Nnaji, Chukwudi A., et al.
Publicado: (2021)

Missed Pneumococcal Vaccination Opportunities in Adults With Invasive Pneumococcal Disease in a Community Health System
por: Schulz, Paul S, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_scgllql57r9po18l8ffo17bcdb